0001654954-22-013277.txt : 20221003
0001654954-22-013277.hdr.sgml : 20221003
20221003194114
ACCESSION NUMBER: 0001654954-22-013277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220930
FILED AS OF DATE: 20221003
DATE AS OF CHANGE: 20221003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brown Michael J
CENTRAL INDEX KEY: 0001035909
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 221289234
MAIL ADDRESS:
STREET 1: C/O EURONET WORLDWIDE, INC.
STREET 2: 11400 TOMAHAWK CREEK PARKWAY, SUITE 300
CITY: LEAWOOD
STATE: KS
ZIP: 66211
FORMER NAME:
FORMER CONFORMED NAME: BROWN MICHAEL J
DATE OF NAME CHANGE: 19970317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
BUSINESS PHONE: 8473880349
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2022-09-30
0001645469
Monopar Therapeutics
MNPR
0001035909
Brown Michael J
1000 SKOKIE BLVD STE 350
WILMETTE
IL
60091
true
false
false
Common Stock
2022-09-30
4
M
false
2859
A
222871
D
Common Stock
4111272.88
I
See Footnote
Common Stock
166667
I
See Footnote
Restricted Stock Units
2022-09-30
4
M
false
2859
0
D
Common Stock
2859
2859
D
Represents shares acquired on vesting and settlement of restricted stock units.
This is based upon the 4,111,272.88 shares of Monopar common stock that Tactic Pharma LLC indirectly controls through TacticGem LLC. As a manager of Tactic Pharma LLC, Mr. Brown may be deemed to share voting and dispositive power over these 4,111,272.88 shares. Mr. Brown disclaims beneficial ownership of the 4,111,272.88 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein.
This is based upon the 166,667 shares of Monopar Common Stock that Tactic Pharma LLC directly owns. As a manager of Tactic Pharma LLC, Mr. Brown may be deemed to share voting and dispositive power over these 166,667 shares. Mr. Brown disclaims beneficial ownership of the 166,667 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein.
On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
/s/ Kim R. Tsuchimoto, Attorney-in-fact
2022-10-03